作者：
Thomas,McKerrell [1]
;
Naomi,Park [2]
;
Jianxiang,Chi [3]
;
Grace,Collord [1]
;
Thaidy,Moreno [4]
;
Hannes,Ponstingl [5]
;
Joao,Dias [1]
;
Petroula,Gerasimou [6]
;
Kiki,Melanthiou [1]
;
Chrystalla,Prokopiou [7]
;
Marios,Antoniades [4]
;
Ignacio,Varela [5]
;
Paul A,Costeas [8]
;
George S,Vassiliou [9]
作者单位：
The Wellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, United Kingdom.
[1]
Department of Haematology, University of Cambridge, Cambridge, United Kingdom.
[2]
Department of Haematology, Cambridge University Hospitals National Health Service Foundation Trust, Cambridge, United Kingdom.
[3]
The Center for the Study of Haematological Malignancies, Nicosia, Cyprus.
[4]
The Karaiskakio Foundation, Nicosia, Cyprus.
[5]
Instituto de Biomedicina y Biotecnología de Cantabria, Santander, Spain.
[6]
Cancer Molecular Diagnosis Laboratory, National Institute for Health Research Biomedical Research Centre, University of Cambridge, Cambridge, United Kingdom.
[7]
Department of Haematology, Nicosia General Hospital, Nicosia, Cyprus; and.
[8]
Department of Haematology, Limassol General Hospital, Limassol, Cyprus.
[9]
DOI
10.1182/bloodadvances.2017007047
PMID
29296738
发布时间
2024-02-10
换一批
换一批
